Research programme: micturition disorder therapeutics - Recordati

Drug Profile

Research programme: micturition disorder therapeutics - Recordati

Alternative Names: REC 0206; REC 0436; REC 0765

Latest Information Update: 15 Sep 2010

Price : $50

At a glance

  • Originator Recordati
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Preclinical Overactive bladder; Urinary incontinence

Most Recent Events

  • 15 Sep 2010 Preclinical development is ongoing in Italy
  • 04 Nov 2004 Early research in Overactive bladder in Italy (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top